← Back to Patent Explorer
US4960770A Expired / Lapsed US ⏱️ 0.0 years remaining

2-alkyl thieno(triazolo)diazepine compounds and pharmaceutical uses thereof

Assignee: Tanabe Pharma Corp
•
Filing: 1988-05-25
•
Granted: 1990-10-02
•
Expires: 2008-05-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Thienotriazolodiazepines of formula (I) and thienodiazepines of formula (II) where Ar is Ph or pyridyl (opt. substd.), R1 and R3 are H or 1-4C alkyl, R2 is H, 1-4C alkyl or trifluoromethyl, R4 is 6-18C straight or branched alkyl, alkenyl or alkynyl. Specifically claimed is 4-(2-chlorophenyl)-2-hexyl-9-methyl -6H-thieno(3,2-f)(1,2,4) triazolo (4,3-a)(1,4-diazepine, 2-hexyl-4-(2-methylphenyl)-6, 9-dimethyl-6H-thieno(3,2-f)(1,2,4) triazolo-(4,3-a)(1,4)diazepine and 9 others.

Inventors

  • 👤 Minoru Moriwaki
  • 👤 Masao Abe
  • 👤 Hiroshi Mikashima
  • 👤 Tetsuya Tahara

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 15:34
CPC Classifications
C; C07; C07D; C07D495/00; C07D495/02; C07D495/04; A; A61; A61P; A61P7/00; A61P9/00; A61P9/08; A61P9/10; C07D495/12; C07D495/14

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 76 words
A thienotriazolodiazepine compound of the formula: ##STR13## wherein Ar is phenyl, pyridyl, substituted phenyl or substituted pyridyl; R 1 and R 3 are the same or different and each is hydrogen, alkyl having 1 to 4 carbon atoms; R 2 is hydrogen, alkyl having 1 to 4 carbon atoms or trifluoromethyl; R 4 is straight or branched chain alkyl, alkenyl or alkynyl having 6 to 18 carbon atoms, or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 76 words
A thienotriazolodiazepine compound of the formula: ##STR13## wherein Ar is phenyl, pyridyl, substituted phenyl or substituted pyridyl; R 1 and R 3 are the same or different and each is hydrogen, alkyl having 1 to 4 carbon atoms; R 2 is hydrogen, alkyl having 1 to 4 carbon atoms or trifluoromethyl; R 4 is straight or branched chain alkyl, alkenyl or alkynyl having 6 to 18 carbon atoms, or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 26 words
A compound of claim 1 selected from the group consisting of 4-(2-chlorophenyl)-2-hexyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 2-hexyl-4-(2-methylphenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 2-hexyl-4-(2-methoxyphenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 4-(2-chlorophenyl)-2-octyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 2-hexyl-4-(4-methylphenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 2-hexyl-4-(3-methylphenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 2-hexyl-4-(3,4,5-trimethoxyphenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 2-hexyl-4-(2,5-dimethylphenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo [4,3-a][1,4]diazepine, 4-(2-chlorophenyl)-2-hexyl-6,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo [4,3-a][1,4]diazepine, 2-hexyl-4-(2-methoxyphenyl)-6,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine and 2-hexyl-4-(2-methylphenyl)-6,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo [4,3-a][1,4]diazepine.
Claim 4
Dependent Claim 27 words
A drug for treatment of circulatory diseases comprising a compound of claim 1 or 2 or a pharmaceutically acceptable acid addition salt thereof as an active ingredient.
Claim 5
Dependent Claim 26 words
A drug of claim 3 for treatment of circulatory diseases which is a coronary vasodilating agent, a drug for heart failure or a cerebral vasodilating agent.
Claim 6
Dependent Claim 32 words
A drug for treatment of various diseases induced by platelet activating factor comprising a compound of claim 1 or 2 or a pharmaceutically acceptable acid addition salt thereof as an active ingredient.

References Cited (Backward Citations)

EP0176927A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-10-01 1994-04-02 1994-10-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-10-01 1998-04-02 1998-10-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-10-01 2002-04-02 2002-10-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag